Mounjaro (tirzepatide) Mounjaro is a newer medication that was FDA-approved for controlling blood sugar in adults with type 2 diabetes, alongside lifestyle changes
Peptide Vials (DSIP, 5 mg each): 8 weeks at ~200 mcg/day avg 23 vials 12 weeks at ~200 mcg/day avg 34 vials 12 weeks at ~300 mcg/day avg 56 vials Insulin Syringes (U-100): Per week: 7 syringes (1/day) 8 weeks: 56 syringes 12 weeks: 84 syringes Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution
It has been studied for its potential ability to support the integrity of the gastrointestinal lining, which may help reduce inflammation and improve gut barrier function
Its direct effect on melanin production makes it the go-to option for patients who want noticeable whitening
Mounjaro operates through two pathways, resulting in better diabetes control and weight management
After disinfecting the rubber stopper with alcohol and allowing complete evaporation, draw the calculated volume of bacteriostatic water into a sterile syringe